New pill tested to fight depression in people with HIV
NCT ID NCT05570812
Summary
This study is testing if a pill called pregnenolone can help reduce depression in people living with HIV. About 120 participants will take either pregnenolone or a placebo (sugar pill) for 8 weeks while staying on their current depression medications. Researchers will use brain scans and blood tests to see if the treatment improves brain activity and reduces inflammation linked to depression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
Contact
Conditions
Explore the condition pages connected to this study.